Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thoratec Starts HeartMate II Study As Centers Apply For New LVAD Payment

This article was originally published in The Gray Sheet

Executive Summary

Thoratec plans to complete a seven-patient, 30-day trial of the HeartMate II continuous-flow left-ventricular assist device at four U.S. centers by the end of 2003

You may also be interested in...



Thoratec Plans HeartMate II Trial In 2004, HeartMate III Study In 2005

Thoratec is proposing a pivotal clinical trial design incorporating both heart transplant candidates and destination left-ventricular assist device therapy patients to evaluate the HeartMate II LVAD

Thoratec Plans HeartMate II Trial In 2004, HeartMate III Study In 2005

Thoratec is proposing a pivotal clinical trial design incorporating both heart transplant candidates and destination left-ventricular assist device therapy patients to evaluate the HeartMate II LVAD

Clash Of The LVADs: Continuous Flow Devices Moved To Lower-Paying DRG

MicroMed is seeking to regain sufficient inpatient reimbursement for its DeBakey left-ventricular assist device by the time Medicare coverage for LVADs as destination therapy becomes effective

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel